{"lose_item": [{"drug2": "CNS depressant medications", "polarity": ["false"], "orig_sen": "CNS depressant medications: Concurrent use of procaine hydrochloride and CNS depressant medications may result in additive depressant effects. ", "drug1": "CNS depressant"}, {"drug2": "voriconazole", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors"}, {"drug2": "itraconazole", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors"}, {"drug2": "ketoconazole", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors"}, {"drug2": "azole antifungals", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors"}, {"drug2": "delavirdine", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors"}, {"drug2": "nelfinavir", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors"}, {"drug2": "indinavir", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors"}, {"drug2": "ritonavir", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors"}, {"drug2": "reverse transcriptase inhibitors", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors"}, {"drug2": "HIV protease inhibitors", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "clarithromycin"}, {"drug2": "HIV protease inhibitors", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "troleandomycin"}, {"drug2": "HIV protease inhibitors", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "erythromycin"}, {"drug2": "HIV protease inhibitors", "polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "macrolide antibiotics"}, {"drug2": "peripheral adrenergic blocking drugs", "polarity": ["false"], "orig_sen": "Potentiation occurs with ganglionic or peripheral adrenergic blocking drugs.", "drug1": "ganglionic adrenergic blocking drugs"}], "cannot_find_item": [], "decode_error": [], "polarity_error": [{"drug2": "phenytoin", "polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "phenytoin"}, {"drug2": "phenytoin", "polarity": ["false", "false", "false", "false", "false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "methotrexate"}, {"drug2": "methotrexate", "polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "methotrexate"}, {"drug2": "phenytoin", "polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "warfarin"}, {"drug2": "methotrexate", "polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "warfarin"}, {"drug2": "phenytoin", "polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "sulfonylurea agents"}, {"drug2": "methotrexate", "polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "sulfonylurea agents"}, {"drug2": "warfarin", "polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "sulfonylurea agents"}, {"drug2": "phenytoin", "polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "cyclosporine"}, {"drug2": "methotrexate", "polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "cyclosporine"}, {"drug2": "warfarin", "polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "cyclosporine"}, {"drug2": "sulfonylurea agents", "polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "cyclosporine"}, {"drug2": "phenytoin", "polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "thiazides"}, {"drug2": "methotrexate", "polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "thiazides"}, {"drug2": "warfarin", "polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "thiazides"}, {"drug2": "sulfonylurea agents", "polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "thiazides"}, {"drug2": "cyclosporine", "polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "thiazides"}, {"drug2": "tricyclic antidepressants", "polarity": ["effect", "effect"], "orig_sen": "The pressor response of adrenergic agents may also be potentiated by tricyclic antidepressants.", "drug1": "adrenergic agents"}, {"drug2": "halothane", "polarity": ["effect", "effect"], "orig_sen": "Vasopressors, particularly metaraminol, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all. ", "drug1": "metaraminol"}, {"drug2": "halothane", "polarity": ["effect", "effect"], "orig_sen": "Vasopressors, particularly metaraminol, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all. ", "drug1": "Vasopressors"}, {"drug2": "metaraminol", "polarity": ["false", "false"], "orig_sen": "Vasopressors, particularly metaraminol, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all. ", "drug1": "Vasopressors"}, {"drug2": "montelukast", "polarity": ["false", "false"], "orig_sen": "Phenobarbital, which induces hepatic metabolism, decreased the AUC of montelukast approximately 40% following a single 10-mg dose of montelukast. ", "drug1": "montelukast"}, {"drug2": "montelukast", "polarity": ["false", "false", "false", "false"], "orig_sen": "Phenobarbital, which induces hepatic metabolism, decreased the AUC of montelukast approximately 40% following a single 10-mg dose of montelukast. ", "drug1": "Phenobarbital"}, {"drug2": "beta-blocking agents", "polarity": ["effect", "effect"], "orig_sen": "Catecholamine-depleting drugs (e.g., reserpine) may have an additive effect when given with beta-blocking agents. ", "drug1": "reserpine"}, {"drug2": "corticosteroids", "polarity": ["advise", "advise"], "orig_sen": "Aspirin should be used cautiously in conjunction with corticosteroids in patients suffering from hypoprothrombinemia. ", "drug1": "Aspirin"}]}